Search
Studies * D:A:D * Publications * 2016

Publications 2016


1. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
. A Mocroft, JD Lundgren, M Ross, CA Fux  P Reiss, O Moranne, P Morlat, A d'Arminio Monforte, O Kirk, L Ryom, on behalf of The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. 
Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8.  abstract

2. Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons. L Ryom, JD Lundgren, S De Wit, H Kovari, P Reiss, M Law, W El-Sadr, A D’Arminio Monforte, Amanda Mocroft, C Smith, E Fontas, F Dabis, A Phillips and C Sabin for the D:A:D Study Group.
AIDS. 2016 Jul 17;30(11):1731-43. doi: 10.1097/QAD.0000000000001018. Abstract

3. Antiretroviral drugs and risk of chronic ALT elevation in HIV-infected persons without viral hepatitis coinfection. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study H Kovari, CA Sabin, B Ledergerber, L Ryom, P Reiss, M Law, C Pradier, F Dabis, A d’Arminio Monforte, C Smith, S de Wit, O Kirk, JD Lundgren, R Weber , on behalf of the D:A:D Study group. 
Open Forum Infect Dis. 2016 Jan 21;3(1):ofw009. doi: 10.1093/ofid/ofw009. eCollection 2016. Abstract

4Is Nelfinavir Exposure Associated with Cancer Incidence in HIV-positive individuals? DC Boettiger, CA Sabin, A Grulich, L Ryom, F Bonnet, P Reiss, A d’ArminioMonforte, O Kirk, A Phillips,  M Bower, G Fätkenheuer, JD Lundgren, M Law on behalf of the Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group
AIDS. 2016 Jun 19;30(10):1629-37. doi: 10.1097/QAD.0000000000001053. Abstract

5. Improvements over time in short-term mortality following myocardial infarction in HIV-positive individuals. CI Hatleberg, L Ryom, W El-Sadr, C Smith, R Weber, P Reiss, E Fontas,  F Dabis, M Law,  A d’Arminio Monforte,  Stephane De Wit,  A Mocroft,  A Phillips,  J D. Lundgren and C Sabin for the D:A:D Study Group
AIDS. 2016 Jun 19;30(10):1583-96. doi: 10.1097/QAD.0000000000001076. abstract

6. Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with human immunodeficiency virus (HIV)? A cohort collaboration. CA Sabin; P Reiss; L Ryom; AN Phillips, PhD; R Weber; M Law; E Fontas; A Mocroft; S de Wit; C Smith; F Dabis; A d'Arminio Monforte; W El-Sadr; JD Lundgren for the DAD Study Group.
BMC Med. 2016 Mar 31;14(1):61. doi: 10.1186/s12916-016-0588-4. Abstract

7. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. Amit C Achhra; Amanda Mocroft; Peter Reiss; Caroline Sabin; Lene Ryom; Stephane de Wit; Colette J Smith; Antonella d´arminio Monforte; Andrew Phillips; Rainer Weber;  Jens Lundgren;  Matthew G Law; The D:A:D Study Group.
HIV Med. 2016 Apr;17(4):255-68. abstract

8. An updated prediction model of the global risk of cardiovascular disease in HIV- positive persons. N Friis-Møller, L Ryom, C Smith, R Weber, P Reiss, F Dabis, S De Wit, A D’Arminio Monforte, O Kirk, E Fontas, C Sabin, A Phillips, J Lundgren, M Law, on behalf of the D:A:D study group. European Journal of Eur J Prev Cardiol. 2016 Jan;23(2):214-23. abstract

9Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study. DA Kamara, CA Sabin, L Ryom, P Reiss, M Rickenbach, CJ Smith, A Phillips, A Mocroft, S De Wit, M Law, A d’Arminio Monforte, F Dabis, C Pradier, JD  Lundgren.
Antivir Ther. 2016;21(6):495-506. doi: 10.3851/IMP3051. Epub 2016 Apr 26. abstract

10. Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study. L Ryom, JD  Lundgren, M Ross, O  Kirk, M  Law, P Morlat, C Smit, E Fontas, CA  Fux, CI  Hatleberg, S de Wit, CA Sabin and A Mocroft for the D:A:D Study Group
J Infect Dis. 2016 Oct 15;214(8):1212-20. doi: 10.1093/infdis/jiw342. Epub 2016 Aug 2. abstract


IN PRESS: